Le Lézard
Classified in: Health
Subjects: CHI, SVY, TRI, DIS, DEI

NIH STUDY SUGGESTS ASSOCIATION BETWEEN PRENATAL DEPRESSION AND GREATER AUTISM-RELATED TRAITS IN CHILDREN


DURHAM, N.C., Aug. 1, 2023 /PRNewswire/ -- Children of mothers with prenatal depression had slightly more autism-related traits compared to those without that exposure, according to a study funded by the Environmental influences on Child Health Outcomes (ECHO) Program at the National Institutes of Health.

While this study didn't explore why this association might exist, future research could investigate whether these findings reflect overlap in genetic risk for depression and autism-related traits or another mechanism.

Prior studies linked prenatal depression and depression history to autism spectrum disorder, but this study focused broadly on autism-related traits. By studying social communication and other autism-related traits, researchers can better understand how prenatal depression influences these traits, which may show up in children without an official diagnosis of autism spectrum disorder.

"Autism-related traits can significantly impact a child's physical, social, and psychological development, regardless of their clinical diagnosis. Screening and treating pregnant patients for depression and detecting autism-related traits in these children early on can lead to timely support of healthy development and outcomes for mothers and children," said study author Lyndsay Avalos, PhD, MPH, of Kaiser Permanente Northern California Division of Research.

The analysis included 3,994 parent-child pairs with prenatal depression data and 1,730 pairs with depression severity data from 33 ECHO research sites across the United States. Autism-related traits were assessed using the Social Responsiveness Scale (SRS) for children up to 12 years of age.

Dr. Avalos and Lisa Croen, PhD, also of Kaiser Permanente Northern California Division of Research, led this collaborative research published in Autism Research.

About ECHO: Launched in 2016, the Environmental influences on Child Health Outcomes (ECHO) Program is a research program in the Office of the Director at the NIH with the mission to enhance the health of children for generations to come. ECHO investigators study the effects of a broad range of early environmental influences on child health and development. For more information, visit echochildren.org.

About the NIH: NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information, visit www.nih.gov.

SOURCE NIH Environmental influences on Child Health Outcomes (ECHO) Program


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: